ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,788, issued on Sept. 16, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"PI4-kinase inhibitors and methods of using the same" was invented by Jeffrey S. Glenn (Palo Alto, Calif.), Mark Smith (San Francisco), Edward A. Pham (Palo Alto, Calif.), Kaustabh Basu (Redwood City, Calif.) and Stephen Stabler (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds and methods are provided for inhibiting a PI4-kinase. Methods of treating a pathogen infection and methods of treating cancer are also provided. The PI4-kinase inhibitor can be a compound that is a 5-aryl or heteroaryl-thiaz...